semaglutide muscle gain probably doesn't lead to disproportional mass loss. In fact, it seems to perhaps spare a bit more muscle than otherwise. PMID: 8089287 I used Semaglutide to get

Antiinflammatory actions of glucagon-like peptide-1based therapies beyond metabolic benefits Text PDF Abstract Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver disease, arthritis, and both substance use and neurodegenerative disorders

He also discusses in his JAMA article that GLP-1 could prevent and treat diabetes, cardiovascular disease and other issues like sleep apnea

Mazdutide has demonstrated remarkably low discontinuation rates (near 1% in early trials) compared to retatrutide (12-18% in Phase 3)

Sleep supports cellular repair and healthy skin regeneration